CARRIE LEACH: Open Payments
NPI 1255684650 · GRAFTON, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$852 in 65 payments from 14 companies in 2025. Trend: 2023 $386 · 2024 $1,613 · 2025 $852
Food & beverage: $852
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 23 | $198 |
| ABBVIE INC. | 15 | $171 |
| Supernus Pharmaceuticals, Inc. | 5 | $80 |
| Teva Pharmaceuticals USA, Inc. | 4 | $68 |
| Otsuka America Pharmaceutical, Inc. | 3 | $57 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $52 |
| Alkermes, Inc. | 3 | $50 |
| Indivior Inc. | 2 | $36 |
| Axsome Therapeutics, Inc. | 2 | $32 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $28 |
Products named: CAPLYTA, VRAYLAR, Qelbree, AUSTEDO XR, TRINTELLIX, ARISTADA, ABILIFY MAINTENA, SUBLOCADE.
Industry payments across WV — which companies pay providers there.
